Comera Life Sciences Holdings, Inc.
Simbol: CMRA
NASDAQ
0.02684
USDPrețul de piață astăzi
-0.0074
Raportul P/E
0.0000
Raportul PEG
0.83M
MRK Cap
- 0.00%
Randament DIV
Comera Life Sciences Holdings, Inc. (CMRA) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 0 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 0 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 0 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 0 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 0 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 0 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 0 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 0 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 0 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 0 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 0 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | 0 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | 0 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 0 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | 0 | 0.3 | -6.2 | 0 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 0 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 0 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | 0 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 0 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | 0 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 0 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | 0 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | 0 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 0 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 0 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | 0 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | 0 | -9.8 | -3.9 | -1.8 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 0 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 0 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 0 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||
income-statement-row.row.operating-income | 0 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | 0 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 0 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | 0 | -24 | -5.3 | -2.1 |
Întrebări frecvente
Ce este Comera Life Sciences Holdings, Inc. (CMRA) totalul activelor?
Comera Life Sciences Holdings, Inc. (CMRA) activele totale sunt 3727113.000.
Care este venitul anual al întreprinderii?
Venitul anual este N/A.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.735.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -1.529.
Care este marja de profit net a întreprinderii?
Marja profitului net este -84.219.
Care este venitul total al întreprinderii?
Venitul total este -9.143.
Care este Comera Life Sciences Holdings, Inc. (CMRA) profitul net (venitul net)?
Profitul net (venitul net) este -24038181.000.
Care este datoria totală a firmei?
Datoria totală este 775048.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 12392727.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 0.000.